Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation.
Organ Transplantation, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.|Organ Transplantation, Department of Surgery, Ospedale San Salvatore, L'Aquila, Italy. samuele.iesari@gmail.com.
Samuele
S
Iesari
Organ Transplantation, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.|Organ Transplantation, Department of Surgery, Ospedale San Salvatore, L'Aquila, Italy.
Quirino
Q
Lai
Division of Kidney Transplant, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Evaldo
E
Favi
Organ Transplantation, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.|Organ Transplantation, Department of Surgery, Ospedale San Salvatore, L'Aquila, Italy.
Francesco
F
Pisani